The detection of specific methylated genes in the blood DNA of GC patients is of potential diagnostic significance, perhaps eventually overriding the value of CEA (carcinoembryonic antigen), a classical tumor marker in the serum. This evidence concerns the gene CEACAM5 and neoplasm.